Skip to main content
EN
Menu

Why Sectra stock moves

Sectra is a Swedish medical imaging IT company.

Written after the close on ·

Why today

15,984 news analyzed today

Sectra is a Swedish medical imaging IT company.

The move was an ordinary one for the stock and no company news explains it.

Over the last five trading days, Sectra fell clearly while the OMX Stockholm 30 was roughly flat, so the stock's weakness this week was its own.

The news from earlier in the week, including the Mount Sinai and Meritus Health deals, was already known when the session opened, so it does not explain the latest move.

The market's broad selling in the session is the most likely driver.

Today's move of −0.97% was 0.9 times a normal day's 1.1%. OMX Stockholm 30 moved −1.01% on the same day.

Sectra −0.97%OMX Stockholm 30 −1.01%In step with the market

Earlier days →

See the chart in ChartCompass, with every move explained →

What analysts expect, and how often they have been right

Analysts’ estimates for Sectra.

Sectra earned more than expected in 4 out of 5 reports.

For comparison, about 46% of reports from Nordic companies beat the estimate in the last three years.

The share moved in the same direction as the earnings surprise in 2 out of 5 reports with a measured move, against about 63% of reports from Nordic companies.

Ratings

Now
Buy 2Hold 1Sell 0

A rating is the analyst’s own opinion about the share.

Price targets

Latest price 327.60 SEK

Price targets
Low 220Average 340High 460

The average target is 340.00 SEK, +4% relative to the latest price of 327.60 SEK. The range is 220.00 SEK–460.00 SEK. A target is the analyst’s estimate of a future share price. 3 analysts gave a target.

Earnings against expectations, and the share’s reaction

Earnings against expectations, and the share’s reaction0.40.50.70.80.92025-09-04: 0.53; Expected EPS: 0.464/9’25−0.8%2025-12-12: 0.77; Expected EPS: 0.5312/12’25−2.4%2026-03-06: 0.81; Expected EPS: 0.706/3’26+14.0%2026-06-05: 0.82; Expected EPS: 0.855/6’26−1.2%2026-09-04: 0.82; Expected EPS: 0.694/9’26−0.1%Next reported quarter: expected earnings per share of 0.85.→25/11

Expected EPSAbove estimateBelow estimateAs expectedSEK

Percentages below show the share’s report-day move; labels are report dates.

Next reported quarter: expected earnings per share of 0.85 SEK (November 25). For the current fiscal year, expected earnings per share changed from 3.63 SEK three months ago to 3.83 SEK now. 2027 estimate: 3.83 SEK. 2028 estimate: 4.95 SEK. One analyst made the estimate for the quarter.

Has the share price followed the business?

Price and earnings moved in the same direction: 2 out of 3 years. Across Nordic companies, that happens in about 60% of years. In 2026, the price changed −14% and earnings per share +0%.

Revenue, profit and market cap

Revenue, profit and market cap (bn SEK)02346692023: 2.352023: 0.3720232024: 2.972024: 0.4320242025: 3.242025: 0.5620252026: 3.552026: 0.562026Now2027: 4.1720272028: 4.8420282023: 31.15312024: 42.23422025: 57.15572026: 49.1749Now: 63.1263

RevenueProfitMarket capHatched bars: analysts’ estimates.bn SEK

Market cap is 17.8 times 2026 revenue, against 13.3 in 2023. Profit in 2026: 564 m SEK.

Assets, liabilities and market cap

Assets, liabilities and market cap (bn SEK)02346692023: 2.742023: 1.4420232024: 3.212024: 1.6420242025: 3.762025: 1.8420252026: 4.472026: 2.342026Now2023: 31.15312024: 42.23422025: 57.15572026: 49.1749Now: 63.1263

AssetsLiabilitiesMarket capbn SEK

Assets minus liabilities leave 2.1 bn SEK for shareholders. Market cap is 29.5 times that equity.

Price and earnings moved in the same direction: 2 out of 3 years.Market cap (Now): 63.1 bn SEKRevenue 2026: 3.5 bn SEK

What the key figures say about Sectra

The figures connect what Sectra earns with what investors pay.

The line shows the share price in the same year, on its own scale. Hatched bars: analysts’ estimates.

Earnings per share3.22 SEK
NowEarnings per share2023: 1.95232024: 2.22242025: 2.92252026: 2.93262027: 3.83272028: 4.95282023: 161.702024: 219.202025: 296.602026: 255.20

Profit divided by the number of shares. Each share represents this much of the earnings.

2023–2026: 1.95 SEK–2.93 SEK. Peers: Getinge 10.39 SEK, Ambu 2.42 DKK, GN Store Nord -1.15 DKK. 2027 estimate: 3.83 SEK (3.73 SEK–3.92 SEK). 2028 estimate: 4.95 SEK (4.54 SEK–5.36 SEK).

Revenue3.7 bn SEK
NowRevenue2023: 2,350,752,000.00232024: 2,965,539,000.00242025: 3,243,278,000.00252026: 3,546,534,000.00262027: 4,165,000,000.00272028: 4,839,500,000.00282023: 161.702024: 219.202025: 296.602026: 255.20

What the company sold during the year.

2023–2026: 2.4 bn SEK–3.5 bn SEK. Peers: Getinge 34.5 bn SEK, Ambu 6.2 bn DKK, GN Store Nord 14.8 bn DKK. 2027 estimate: 4.2 bn SEK (4.1 bn SEK–4.2 bn SEK). 2028 estimate: 4.8 bn SEK (4.7 bn SEK–5.0 bn SEK).

Operating margin20.9%
NowOperating margin2023: 19.38232024: 17.65242025: 22.29252026: 20.21262023: 161.702024: 219.202025: 296.602026: 255.20

The percentage of revenue left after the costs of running the business.

2023–2026: 17.6%–22.3%. Peers: Getinge 13.6%, GN Store Nord 3.6%.

Return on equity28.3%
NowReturn on equity2023: 28.92232024: 27.29242025: 29.39252026: 26.40262023: 161.702024: 219.202025: 296.602026: 255.20

Profit as a percentage of shareholders’ money in the company.

2023–2026: 26.4%–29.4%. Peers: Getinge 9.1%, Ambu 8.4%, GN Store Nord 2.6%.

P/E101.7
NowP/E2023: 82.92232024: 98.74242025: 101.58252026: 87.10262027: 85.65272028: 66.1828

The price investors pay for each unit of annual earnings per share. Not shown for a loss.

2023–2026: 82.9–101.6. Peers: Getinge 26.7, Ambu 36.2. 2027 estimate: 85.6. 2028 estimate: 66.2.

Market cap per unit of revenue (P/S)16.86
NowMarket cap per unit of revenue (P/S)2023: 13.25232024: 14.24242025: 17.62252026: 13.86262027: 15.15272028: 13.0428

What investors pay for each unit the company sells.

2023–2026: 13.25–17.62. Peers: Getinge 2.20, Ambu 3.66, GN Store Nord 1.22. 2027 estimate: 15.15. 2028 estimate: 13.04.

Dividend per share2.30 SEK
NowDividend per share2017: 0.90172018: 0.90182019: 0.90192020: 0.90202021: 0.90212022: 1.00222023: 1.10232024: 1.10242025: 2.1025

Money paid to shareholders per share, summed by calendar year.

2017–2025: 0.90 SEK–2.10 SEK.

Dividend yield0.4%
NowDividend yield2023: 0.68232024: 0.50242025: 0.71252026: 0.9026

The ordinary yearly dividend as a percentage of the share price. In the past 12 months, the company paid 2.30 SEK per share, 0.7% of the share price.

2023–2026: 0.5%–0.9%. Peers: Getinge 1.7%, Ambu 0.5%, GN Store Nord 0.0%.

Net debt / EBITDA-2.00
NowNet debt / EBITDA2023: -1.51232024: -1.18242025: -1.49252026: -2.0326

Net debt divided by operating earnings before depreciation and amortisation.

2023–2026: -2.03–-1.18. Peers: Getinge 1.33, Ambu -0.14, GN Store Nord 3.56.

More key figures
Market cap / equity (P/B)27.19
NowMarket cap / equity (P/B)2023: 24.03232024: 26.91242025: 29.81252026: 23.0226

Market cap divided by shareholders’ equity, what remains after liabilities.

2023–2026: 23.02–29.81. Peers: Getinge 2.32, Ambu 3.76, GN Store Nord 1.71.

EV / EBIT64.4
2026EV / EBIT2023: 62.92232024: 74.56242025: 76.50252026: 64.4126

Market cap plus net debt, divided by operating earnings. This includes debt.

2023–2026: 62.9–76.5.

Free cash flow per share4.00 SEK
NowFree cash flow per share2023: 1.80232024: 0.39242025: 4.22252026: 4.72262023: 161.702024: 219.202025: 296.602026: 255.20

Cash left after investments, divided by the number of shares.

2023–2026: 0.39 SEK–4.72 SEK. Peers: Getinge 15.86 SEK, GN Store Nord 0.92 DKK.

Equity ratio47.7%
2026Equity ratio2023: 47.38232024: 48.88242025: 51.03252026: 47.7426

The percentage of assets financed by shareholders’ equity.

2023–2026: 47.4%–51.0%.

The dividend explained

A dividend is money paid to shareholders. Sectra paid 2.30 SEK per share in the twelve months through November 6, 2026.

On the ex-dividend day, September 9, 2026, Sectra traded without the right to the 2.30 SEK dividend. The price went from 290.60 SEK to 284.80 SEK; including the dividend, the day's change was −1.2%. Entitlement passes from the company to shareholders on the ex-day; payment comes later.

2017: 0.90 SEK2018: 0.90 SEK2019: 0.90 SEK2020: 0.90 SEK2021: 0.90 SEK2022: 1.00 SEK2023: 1.10 SEK2024: 1.10 SEK2025: 2.10 SEK2026 so far: 2.30 SEK

What followed similar falls?

Including reinvested dividends, Sectra fell 5.3% over the latest five trading days. Since November 7, 2016, falls at least this large were followed by a higher value 21 trading days later in 34 out of 57 non-overlapping periods. The median was +2.9%, against +2.9% for an ordinary 21-day period, which ended higher 60 times in 100.

Such a fall has not said much about the next month.

+2.9% · 34/57

What to watch next, and why

The earnings report shows how Sectra's revenue and profit have changed.

  • Earnings report

    The earnings report shows how Sectra's revenue and profit have changed.

    Add to calendar

Earnings report

Next report: · Add to calendar · Google Calendar

Report day2.4%

Normal day1.1%

On its last 15 report days Sectra usually moved about 2.4%. On a normal day it moves 1.1%.

−0.14% −1.21% +13.98% −2.35%

10,000 SEK in Sectra bought on November 7, 2016 is worth 135,000 SEK today, with dividends reinvested.

What would 10,000 SEK in Sectra be worth today? →

What would 10,000 SEK in Sectra be worth today?

135,000 SEK

with dividends reinvested, bought on November 7, 2016.

The five biggest days of the journey

· −17.9% · the whole market fell 0.1% the same day · report day

· +16.1% · the whole market rose 0.6% the same day · report day

· −14.1% · the whole market fell 1.6% the same day · report day

· +14.0% · the whole market fell 1.3% the same day · report day

· +13.9% · the whole market fell 0.8% the same day · report day

Earlier days

  • −5.32% market −0.11% Sectra fell clearly over the week's trading days, while the broader Stockholm market stayed roughly flat. Read →

    Sectra fell clearly over the week's trading days, while the broader Stockholm market stayed roughly flat.

    The company announced a new radiology reporting deal with Mount Sinai Health System in New York on Wednesday, 4 November, which is company news but did not lift the shares.

    Its moves were ordinary in size, with trading volume well below its usual level, so the decline looks more like a stock-specific pullback than a market-wide selloff.

    Sectra's next report is due on Wednesday, 25 November 2026.

  • +1.22% market −0.32% Sectra rose slightly, without company news. Read →

    Sectra rose slightly, without company news.

    Sectra's move was an ordinary one for the stock, within its usual daily range.

    Company news from before the session, including a new deal with Mount Sinai Health System in New York, may have supported sentiment.

    However, the news was known when the session opened, and nothing dated to that session explains the rise.

    Over the last five trading days, Sectra fell clearly while the market rose slightly.

  • +0.68% market +0.83% Sectra rose, moving in line with a rising OMX Stockholm 30 market. Read →

    Sectra rose, moving in line with a rising OMX Stockholm 30 market.

    A Mount Sinai Health System agreement for Sectra Reporting, announced that day, is the company news from the session.

    Over the last five trading days, Sectra fell clearly while the market edged up, so the stock moved against the market.

    The move was an ordinary-sized day for Sectra, and the stock still sits well above its mid-February low but below its late-October high.

  • −1.81% market −0.08% Sectra fell, while the OMX Stockholm 30 was roughly flat. Read →

    Sectra fell, while the OMX Stockholm 30 was roughly flat.

    No company news from that session explains the move.

    Over the last five trading days Sectra fell clearly, moving against a slightly rising market.

    Its share price sits well above its low from mid February but below its late October high.

    The Meritus Health cloud go-live announced on October 29 came before the session and is background, not a same-day trigger.

  • −4.45% market +0.48% Sectra fell, moving against a rising market. Read →

    Sectra fell, moving against a rising market.

    No company news from that session explains the drop.

    Over the five trading days Sectra fell slightly while OMX Stockholm 30 rose clearly.

    The move was about four times a normal day for Sectra, and trading volume was about twice its usual level.

    Earlier news, a Meritus Health cloud go-live announced on October 29, was already known before the session opened.

  • +2.91% market +3.01% Sectra rose clearly over the week, moving in line with the broader Stockholm market. Read →

    Sectra rose clearly over the week, moving in line with the broader Stockholm market.

    The main company news was the go-live of Sectra One Cloud at Meritus Health, a US healthcare provider, announced on Thursday 29 October.

    Cloud services are software run over the internet, so new customers add recurring revenue.

    The share price sits near its highest level of the past year.

  • +0.53% market +0.33% Sectra, a Swedish medical imaging and secure communications firm, barely moved. Read →

    Sectra, a Swedish medical imaging and secure communications firm, barely moved.

    Sectra rose slightly over the last five trading days, a little more than OMX Stockholm 30, which also rose slightly.

    The move was an ordinary day for Sectra, within its usual daily range, and trading was well below its usual level.

  • +0.18% market +0.96% Sectra was roughly unchanged, while Stockholm's market rose clearly. Read →

    Sectra was roughly unchanged, while Stockholm's market rose clearly.

    Its move was an ordinary one for the stock.

    No company news from that session explains it.

    Over the past five trading days, Sectra rose clearly while the market was roughly flat.

    Earlier news, dated last week, covered Swedish government approval of its secure phone and a buy recommendation from William O'Neil.

  • +0.06% market +1.57% Sectra stayed roughly flat, while the market rose. Read →

    Sectra stayed roughly flat, while the market rose.

    Over five days Sectra rose clearly, though the market fell slightly.

    Its price sits near its highest close of the past year.

    The most likely support is the Swedish approval of its secure phone for classified information, which came in the days before, though this approval was not the last session's news.

    Analysts' buy recommendations and sector gains may also add support.

  • +0.42% market +0.41% Sectra was roughly unchanged, moving less than the market. Read →

    Sectra was roughly unchanged, moving less than the market.

    No company news explains it.

    Over the last five trading days, Sectra rose sharply while OMX Stockholm 30 fell sharply, so it moved against the market.

    The rise likely reflects the October 15 approval for its stationary secure phone to handle SECRET-level information, plus the buy rating from William O'Neil.

    Sectra sits near its one-year high, well above its February low.

  • +6.12% market −3.67% Sectra, listed on Nasdaq Stockholm as SECT-B, rose sharply over the last five trading days while the broader Stockholm market fell. Read →

    Sectra, listed on Nasdaq Stockholm as SECT-B, rose sharply over the last five trading days while the broader Stockholm market fell.

    The move was likely driven by Swedish government approval of its stationary secure phone for classified SECRET information, news that reached the market in the days before the window and again early in the week.

    An analyst initiation with a buy rating, meaning a recommendation to purchase the shares, added to the positive tone midweek.

    Sectra's latest close sits near the top of its one-year range, so the shares are strong.

  • +2.48% market +0.17% Sectra rose sharply; no company news explains it. Read →

    Sectra rose sharply; no company news explains it.

    Sectra rose sharply in the last session while the OMX Stockholm 30 was roughly flat.

    No company news from that session explains the move.

    Over the last five trading days, Sectra rose sharply while the OMX Stockholm 30 fell slightly.

    Earlier this month the company won Swedish approval for a stationary phone for secret information, and signed a UK pathology deal with Diagnexia; these may have added to the rise.

Learn more · Why do stocks go up and down?

All companies